M. V. Varas Lorenzo, E. Cugat Andorra, J. Capdevila Castillón
tlooto Summary
Endocrine or pancreatic neuroendocrine tumors (PNET) were first cited in the 1950s and nowadays, NF-PNETs are the most frequent and their prevalence ranges from 50% to 91%.
Abstract
Endocrine or pancreatic neuroendocrine tumors (PNET) were first cited in the 1950s; they may be sporadic or associated with hereditary syndromes, benign or malignant, functioning or non-functioning. Nowadays, NF-PNETs are the most frequent and their prevalence ranges from 50% to 91%. In our current series (including 70 cases, 33% malignant, 52 operated) the frequency was 72% as compared to 37% in the historical series.
Citation format
LORENZO, M. V. Varas; ANDORRA, E. Cugat; CASTILLÓN, J. Capdevila. Pancreatic neuroendocrine tumors. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 6: 480–481.